2007
DOI: 10.1016/j.vaccine.2007.05.023
|View full text |Cite
|
Sign up to set email alerts
|

Use of tetanus toxoid as a differentiating infected from vaccinated animals (DIVA) strategy for sero-surveillance of avian influenza virus vaccination in poultry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
18
0

Year Published

2008
2008
2021
2021

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 13 publications
(20 citation statements)
references
References 12 publications
2
18
0
Order By: Relevance
“…Next, a divalent vaccine composed of both TT and whole inactivated H6N2 antigens emulsified with mineral oil (Montanide ISA-70 VG) was prepared, using three separate doses of TT (0.15, 0.3 and 0.6 mg), as described previously [10]. The vaccine was delivered Fig.…”
Section: Antibody Responses In Ducks Vaccinated With a Combined Tt Anmentioning
confidence: 99%
See 4 more Smart Citations
“…Next, a divalent vaccine composed of both TT and whole inactivated H6N2 antigens emulsified with mineral oil (Montanide ISA-70 VG) was prepared, using three separate doses of TT (0.15, 0.3 and 0.6 mg), as described previously [10]. The vaccine was delivered Fig.…”
Section: Antibody Responses In Ducks Vaccinated With a Combined Tt Anmentioning
confidence: 99%
“…We have previously evaluated tetanus toxoid (TT) as an exogenous marker for AI vaccines in chickens and showed that there is no interference with TT or AI H-specific antibody responses in TT-and AI-co-vaccinated chickens [10]. The TT marker was selected on the basis that chickens are highly resistant to tetanus (chicken toxic dose is 350,000 times the equine toxic dose per gram body weight) [11], are not routinely vaccinated with TT, and naturally existing antibodies to TT are absent in chickens from a variety of sources.…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations